BrightSpring Health Services, Inc. (BTSG)
(Delayed Data from NSDQ)
$11.30 USD
+0.06 (0.53%)
Updated May 14, 2024 04:00 PM ET
After-Market: $11.29 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth C Momentum A VGM
BrightSpring Health Services, Inc. (BTSG) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$16.14 | $23.00 | $13.00 | 43.59% |
Price Target
Based on short-term price targets offered by 11 analysts, the average price target for BrightSpring Health Services, Inc. comes to $16.14. The forecasts range from a low of $13.00 to a high of $23.00. The average price target represents an increase of 43.59% from the last closing price of $11.24.
Analyst Price Targets (11)
Broker Rating
BrightSpring Health Services, Inc. currently has an average brokerage recommendation (ABR) of 1.05 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 11 brokerage firms. The current ABR compares to an ABR of 1.05 a month ago based on 11 recommendations.
Of the 11 recommendations deriving the current ABR, 10 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 90.91% and 9.09% of all recommendations. A month ago, Strong Buy made up 90.91%, while Buy represented 9.09%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 8 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.05 | 1.05 | 1.05 | 1.05 | 1.25 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
2/20/2024 | SVB Securities | Whit Mayo | Not Available | Strong Buy |
2/20/2024 | Guggenheim Securities | Jack D Wallace | Not Available | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.05 |
ABR (Last week) | 1.05 |
# of Recs in ABR | 11 |
Average Target Price | $16.14 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 90 of 252 |
Current Quarter EPS Est: | 0.20 |